Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 44, 2020 - Issue 5
182
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Case Series and Review of Hematological and Non-Hematological Malignancies in Aging Patients with Sickle Cell Disease in the Hydroxyurea Era

, , ORCID Icon & ORCID Icon
Pages 303-306 | Received 18 Jun 2020, Accepted 19 Jul 2020, Published online: 02 Dec 2020

References

  • Lê PQ, Gulbis B, Dedeken L, et al. Survival among children and adults with sickle cell disease in Belgium: benefit from hydroxyurea treatment. Pediatr Blood Cancer. 2015;62(11):1956–1961.
  • Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639–1644.
  • Steinberg MH, McCarthy WF, Castro O, et al. Investigation of the Multicenter Study of Hydroxyurea and Sickle Cell Anemia and MSH Patient’s Follow-Up. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up. Am J Hematol. 2010;85(6):403–408.
  • Wierenga KJ, Hambleton IR, Lewis NA. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet. 2001;357(9257):680–683.
  • Ballas SK, Pulte ED, Lobo C, et al. Case series of octogenarians with sickle cell disease. Blood. 2016;128(19):2367–2369.
  • Steinberg MH, Ballas SK, Brunson CY, et al. Sickle cell anemia in septuagenarians. Blood. 1995;86(10):3997–3998.
  • Goldin AG, Kelty KC, Beard MF. Sickle cell anemia terminating in acute myeloblastic leukemia. Ann Intern Med. 1953;39(4):920–928.
  • Stricker RB, Linker CA, Crowley TJ, et al. Hematologic malignancy in sickle cell disease: report of four cases and review of the literature. Am J Hematol. 1986;21(2):223–230.
  • Thomas AN, Pattison C, Serjeant GR. Causes of death in sickle-cell disease in Jamaica. Br Med J (Clin Res Ed). 1982;285(6342):633–635.
  • Powars DR. Natural history of sickle cell disease–the first ten years. Semin Hematol. 1975;12(3):267–285.
  • Perrine RP, Pembrey ME, John P, et al. Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects. Ann Intern Med. 1978;88(1):1–6.
  • Dawkins FW, Kim KS, Squires RS, et al. Cancer incidence rate and mortality rate in sickle cell disease patients at Howard University Hospital: 1986–1995. Am J Hematol. 1997;55(4):188–192.
  • Seminog OO, Ogunlaja OI, Yeates D, Goldacre MJ. Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study. J R Soc Med. 2016;109(8):303–309.
  • Brunson A, Keegan THM, Bang H, et al. Increased risk of leukemia among sickle cell disease patients in California. Blood. 2017;130(13):1597–1599.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.